After an elevated PSA level or the detection of a suspicious area on a prostate MRI, one of the first questions many patients face is:
“I have been told that I need an MRI fusion biopsy. What is this procedure?”
One of the most important developments in prostate cancer diagnosis in recent years has been multiparametric prostate MRI imaging and MRI fusion biopsy technology.
The purpose of a prostate biopsy is to obtain samples from prostate tissue in order to determine whether prostate cancer is present.
A biopsy decision may be considered in cases of:
In a traditional prostate biopsy, systematic samples are taken from different regions of the prostate under ultrasound guidance.
In this method, sampling is performed from specific anatomical regions.
However, some small or difficult-to-locate tumors may be missed during systematic biopsies.
This situation can be an important problem, especially in patients who have previously undergone biopsy but did not receive a diagnosis.
MRI fusion biopsy is based on combining prostate MRI images with real-time ultrasound images.
First, the patient undergoes a multiparametric prostate MRI examination.
Suspicious areas are marked on the MRI.
During the biopsy, these MRI images are matched with ultrasound images using special software.
This allows the suspicious area to be targeted directly.
For this reason, the procedure is also described as a “targeted biopsy.”
Prostate MRI reports frequently use an assessment system called PI-RADS.
The PI-RADS score indicates how suspicious an area within the prostate is for prostate cancer.
In general:
However, a definitive diagnosis can only be made through biopsy.
This question is frequently asked by patients.
Today, MRI fusion biopsy is generally performed under sedation or appropriate anesthesia methods.
For this reason, most patients do not feel significant pain during the procedure.
After the procedure, mild discomfort or short-term bleeding may occur.
After biopsy:
may continue for a period of time.
In most cases, these findings are temporary and resolve on their own.
However, a physician should be consulted in cases such as high fever, heavy bleeding, or inability to urinate.
No.
Each patient should be evaluated individually.
When making the decision:
are evaluated together.
The aim is to avoid unnecessary biopsies while not missing clinically significant prostate cancers.
If prostate cancer is detected as a result of the biopsy, the disease is evaluated together with:
The same treatment is not applied to every patient with prostate cancer.
While some patients may be placed in an active surveillance program, surgery or radiotherapy may be recommended for others.
By combining multiparametric prostate MRI images with targeted biopsy, clinically significant prostate cancers can be detected with higher accuracy.
In cases of elevated PSA or suspicious findings on prostate MRI, MRI fusion biopsy may contribute to a more accurate diagnosis and more personalized treatment planning in appropriate patients.
Assoc. Prof. Dr. Serdar Yalçın
Urology Specialist
MRI Fusion Prostate Biopsy • Prostate Cancer • Robotic Urology • Urologic Oncology • Minimally Invasive Diagnostic and Treatment Methods
Bu makalenin DoktorTakvimi web sitesinde yayımlanması, yazarın açık izniyle yapılmaktadır. Web sitesindeki tüm içerikler, fikri ve sınai mülkiyet mevzuatı kapsamında uygun şekilde korunmaktadır.
DocPlanner Teknoloji A.Ş. web sitesi tıbbi tavsiye sunmaz. Bu sayfanın içeriği, metinler, grafikler, görseller ve diğer materyaller de dahil olmak üzere, yalnızca bilgilendirme amacıyla oluşturulmuştur ve tıbbi tavsiye, teşhis veya tedavinin yerini almak amacı taşımaz. Herhangi bir sağlık sorununuzla ilgili şüpheniz varsa, bir uzmana danışınız.
15/06/2026
11/06/2026
11/06/2026